Managing Horseshoe Crab Conservation in a Time of COVID

The LAL reagent, comprised of enzymes from the American Horseshoe Crab (Limulus polyphemus), is an essential test to assure pharmaceuticals and medical products are free of potentially life threatening bacterial contamination.  This is true for routine production as well as new product development, such as the current flurry of new vaccines and drugs to address COVID-19.  Does this create a stress on supplies of LAL?  Are there alternatives that could alleviate the situation?  What is the possibility of using recombinant DNA technology to fill this need?  Join Dr. Norm Wainwright, from Charles River Laboratories, and we’ll discuss this in the context of medical needs and conservation concerns.

Registration open here.